Abstract
Overexpression of MYC transforms cells in culture, elicits malignant tumours in experimental animals and is found in many human tumours. We now report the paradoxical finding that this powerful oncogene can also act as a suppressor of cell motility, invasiveness and metastasis. Overexpression of MYC stimulated proliferation of breast cancer cells both in culture and in vivo as expected, but inhibited motility and invasiveness in culture, and lung and liver metastases in xenografted tumours. We show further that MYC represses transcription of both subunits of αvβ3 integrin, and that exogenous expression of β3 integrin in human breast cancer cells that do not express this integrin rescues invasiveness and migration when MYC is downregulated. These data uncover an unexpected function of MYC, provide an explanation for the hitherto puzzling literature on the relationship between MYC and metastasis, and reveal a variable that could influence the development of therapies that target MYC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653–699 (2000).
Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2, 764–776 (2002).
Dang, C. V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell Biol. 19, 1–11 (1999).
Kuttler, F. & Mai, S. c-Myc, genomic instability and disease. Genome Dyn. 1, 171–190 (2006).
Oster, S. K., Ho, C. S., Soucie, E. L. & Penn, L. Z. The myc oncogene: MarvelouslY Complex. Adv. Cancer Res. 84, 81–154 (2002).
Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635–645 (2005).
Meyer, N. & Penn, L. Z. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976–990 (2008).
Nesbit, C. E., Tersak, J. M. & Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene 18, 3004–3016 (1999).
Alitalo, K. & Schwab, M. Oncogene amplification in tumor cells. Adv. Cancer Res. 47, 235–281 (1986).
Boxer, R. B., Jang, J. W., Sintasath, L. & Chodosh, L. A. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 6, 577–586 (2004).
Liao, D. J. & Dickson, R. B. c-Myc in breast cancer. Endocr. Relat. Cancer 7, 143–164 (2000).
Pompetti, F. et al. Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J. Cell Biochem. 63, 37–50 (1996).
Shiu, R. P., Watson, P. H. & Dubik, D. c-myc oncogene expression in estrogen-dependent and -independent breast cancer. Clin. Chem. 39, 353–355 (1993).
D’Cruz, C. M. et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 7, 235–239 (2001).
Leder, A., Pattengale, P. K., Kuo, A., Stewart, T. A. & Leder, P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45, 485–495 (1986).
Sinn, E. et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49, 465–475 (1987).
Stewart, T. A., Pattengale, P. K. & Leder, P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38, 627–637 (1984).
Welm, A. L., Kim, S., Welm, B. E. & Bishop, J. M. MET and MYC cooperate in mammary tumorigenesis. Proc. Natl Acad. Sci. USA 102, 4324–4329 (2005).
Frye, M., Gardner, C., Li, E. R., Arnold, I. & Watt, F. M. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development 130, 2793–2808 (2003).
Waikel, R. L., Kawachi, Y., Waikel, P. A., Wang, X. J. & Roop, D. R. Deregulated expression of c-Myc depletes epidermal stem cells. Nat. Genet. 28, 165–168 (2001).
Guo, W. & Giancotti, F. G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816–826 (2004).
Hood, J. D. & Cheresh, D. A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91–100 (2002).
Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: A dynamic niche in cancer progression. J. Cell Biol. 196, 395–406 (2012).
Felding-Habermann, B. Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 20, 203–213 (2003).
Mizejewski, G. J. Role of integrins in cancer: survey of expression patterns. Proc. Soc. Exp. Biol. Med. 222, 124–138 (1999).
Gebhardt, A. et al. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J. Cell Biol. 172, 139–149 (2006).
De Nigris, F. et al. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of α3β1-integrin in tumour cells. Oncogene 26, 382–394 (2007).
Van Golen, C. M., Soules, M. E., Grauman, A. R. & Feldman, E. L. N-Myc overexpression leads to decreased β1 integrin expression and increased apoptosis in human neuroblastoma cells. Oncogene 22, 2664–2673 (2003).
Wilson, A. et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18, 2747–2763 (2004).
Xiao, J., Jethanandani, P., Ziober, B. L. & Kramer, R. H. Regulation of α7 integrin expression during muscle differentiation. J. Biol. Chem. 278, 49780–49788 (2003).
Husemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58–68 (2008).
Ridley, A. J. et al. Cell migration: integrating signals from front to back. Science 302, 1704–1709 (2003).
Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362–374 (2003).
Carman, C. V. & Springer, T. A. Integrin avidity regulation: are changes in affinity and conformation underemphasized?. Curr. Opin. Cell Biol. 15, 547–556 (2003).
Bauer, K., Mierke, C. & Behrens, J. Expression profiling reveals genes associated with transendothelial migration of tumor cells: a functional role for αvβ3 integrin. Int. J. Cancer 121, 1910–1918 (2007).
Wanzel, M., Herold, S. & Eilers, M. Transcriptional repression by Myc. Trends Cell Biol. 13, 146–150 (2003).
Small, M. B., Hay, N., Schwab, M. & Bishop, J. M. Neoplastic transformation by the human gene N-myc. Mol. Cell Biol. 7, 1638–1645 (1987).
Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223–238 (2003).
Jamerson, M. H., Johnson, M. D. & Dickson, R. B. Of mice and Myc: c-Myc and mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia 9, 27–37 (2004).
Arvanitis, C. & Felsher, D. W. Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin. Cancer Biol. 16, 313–317 (2006).
Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199–207 (1999).
Liu, H., Radisky, D. C. & Bissell, M. J. Proliferation and polarity in breast cancer: untying the Gordian knot. Cell Cycle 4, 646–649 (2005).
Liu, H., Radisky, D. C., Wang, F. & Bissell, M. J. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J. Cell Biol. 164, 603–612 (2004).
Liu, H. et al. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc. Natl Acad. Sci. USA 103, 4134–4139 (2006).
Liapis, H., Flath, A. & Kitazawa, S. Integrin αvβ3 expression by bone-residing breast cancer metastases. Diagn. Mol. Pathol. 5, 127–135 (1996).
Desgrosellier, J. S. et al. An integrin α(v)β(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat. Med. 15, 1163–1169 (2009).
Ma, L. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247–256 (2010).
Rapp, U. R. et al. MYC is a metastasis gene for non-small-cell lung cancer. PLoS One 4, e6029 (2009).
Wolfer, A. et al. MYC regulation of a ‘poor-prognosis’ metastatic cancer cell state. Proc. Natl Acad. Sci. USA 107, 3698–3703 (2010).
Vita, M. & Henriksson, M. The Myc oncoprotein as a therapeutic target for human cancer. Semin. Cancer Biol. 16, 318–330 (2006).
Acknowledgements
We thank D. Cheresh, F. G. Giancotti, A. Goga and D. Sheppard for providing DNA constructs and cell lines. We are grateful to C-Y. Chen, L. Prentice and B. Edenfeld for help with histology and imaging. We thank D. Khauv for work with the ChIP assay, E. Miller for work with the orthotopic animal assay, M. Cichon for cloning constructs and M. Stallings-Mann for work with analysis of experiments. We also thank members of the Bishop, Bissell and Radisky laboratories for their constructive discussion and help. This work was financially supported initially by the George Williams Hooper Foundation (J.M.B.). The founder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Further support came from NIH (P50 CA091956) and the DoD (PC094054) (to E.S.R.); NCI CA122086, Susan B. Komen foundation grant FAS0703855 and the Mayo Clinic Breast Cancer SPORE grant CA116201 (to D.C.R.); the DoD (W81XWH0810736), NIH/NCI (R37CA064786, U01CA143233, U54CA143836 and U54CA126552) and the Department of Energy OBER Low Dose Radiation Program (contract no. DE-AC02-05CH1123) (to M.J.B.).
Author information
Authors and Affiliations
Contributions
H.L., D.C.R., D.Y., E.S.R., M.J.B. and J.M.B. designed the research; H.L., D.C.R., R.X., E.S.R. and D.Y. performed research; H.L., D.Y., D.C.R., E.S.R., M.J.B. and J.M.B. analysed data; H.L., D.C.R., M.J.B. and J.M.B. wrote the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 535 kb)
Rights and permissions
About this article
Cite this article
Liu, H., Radisky, D., Yang, D. et al. MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat Cell Biol 14, 567–574 (2012). https://doi.org/10.1038/ncb2491
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2491
This article is cited by
-
Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs
Stem Cell Reviews and Reports (2024)
-
FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation
Oncogene (2023)
-
CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways
Science China Life Sciences (2022)
-
αvβ3 Integrin induces partial EMT independent of TGF-β signaling
Communications Biology (2021)
-
Cancer progression and the invisible phase of metastatic colonization
Nature Reviews Cancer (2020)